StockData
Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc. (MRVI) stock

MRVINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30170% above fair value
$7.40−0.14 (-1.86%)

Close on Nov 16, 2026Market cap $1.92BP/E –Yield –

Maravai LifeSciences EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Maravai LifeSciences's EV/EBITDA was 14.9× on Jan 31, 2024, against 5.7× a year earlier. Over the last 2 years it ranged from 5.6× to 367.8×, with a median of 9.2×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 202414.9×−1.4
2023Dec 29, 202316.3×+10.7
2022Dec 30, 20225.6×−362.2
2021Jan 29, 2021367.8×+71.9
2020Dec 31, 2020295.9×–

More Maravai LifeSciences figures

See a number that looks wrong?